OHSU

Rita M. Braziel, M.D.

Head Shot of Rita Braziel
Email: 
click here
Office: 
503 494-6775

Background

The focus of Dr. Braziel's services include hematopathology, which comprise of bone marrow, lymph nodes, hemepath flow cytometry and hemepath molecular diagnostic cases. Her clinical areas of interest are all areas of diagnostic hematopathology and standardization of molecular diagnostic in hematopathology. Dr. Braziel currently serves as the director of Hematopathology at OHSU.


Selected Publications

"A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine- tositumomab," Clinical Cancer Research (Vol: 19, Issue: 23, Page 6624-6632) - 2013

"Colorimetric in situ hybridization identifies MYC gene signal clusters correlating with increased copy number, mRNA, and protein in diffuse large b-cell lymphoma," American Journal of Clinical Pathology (Vol: 139, Issue: 2, Page 242-254) - 2013

"EZH2 mutations are frequent and represent an early event in follicular lymphoma.," Blood (Vol: 122, Issue: 18, Page 3165-3168) - 2013

"Genome-wide methylation analyses identify a subset of mantle cell lymphoma with a high number of methylated CpGs and aggressive clinicopathological features," International Journal of Cancer (Vol: 133, Issue: 12, Page 2852-2863) - 2013

"Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus 131iodine-tositumomab for previously untreated follicular non-hodgkin lymphoma: SWOG S0016," Journal of Clinical Oncology (Vol: 31, Issue: 3, Page 314-320) - 2013

 

Back to faculty list

For Healthcare Professionals


Contact

  Email Rita Braziel

503 494-6775

Memberships & Associations

Pathology-Anatomic and Clinical, 1981